Pharma Focus Asia

GE Healthcare Life Sciences to Build New Manufacturing Facility in Switzerland

Introduction:

GE Healthcare Life Sciences is building a new manufacturing facility, in the new Signy Park, in Grens, Switzerland.

Features:

The main focus of the 7,360 square meter facility will be the manufacture of single-use kits for the Sepax and Sefia cell processing systems.

The Sepax and Sefia cell processing systems are intended to automate processing steps during cell and gene therapy development.

Through the use of a separation chamber manifolded to cell bags, these kits enable a variety of protocols including Cellwash, Culture Wash, Adipose protocols, Dilution, Cell Harvesting, and Expansion.

However, it will also house a Center of Excellence that will include advanced cell and gene therapy manufacturing facilities, as well as an R&D  team.

The facility will also serve as a base for European customer training and educational initiatives.

The site is expected to be fully operational in 2022 and will be able to house up to 200 employees.

Specifications:

NameGE Healthcare Life Sciences
TypeConstruction
LocationSwitzerland
magazine-slider-imageCytiva - Supor Prime filtersMFA + MMA 20244th Annual Cleaning Validation 20242nd Annual Pharma Impurity Conclave 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference